Actor turned rare disease advocate Luke Rosen tells how his daughter, Susannah, lives with a KIF1A-associated neurological ...
Hackathons using AlphaGenome and other AI models are hunting down the genetic causes of devastating conditions that have ...
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...
U.S. President Donald Trump signed a spending package into law Tuesday that reauthorizes the FDA’s previously stalled rare ...
Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...
After more than a year out in the cold, the programme’s reauthorisation is a boost for rare disease therapy developers.
The Consolidated Appropriations Act of 2026, signed by Trump on Feb. 3, includes a provision reinstating the Mikaela Naylon ...
Niagara-on-the-Lake’s Matt Finlin has built an accomplished career in the not-for-profit and film worlds, producing ...
Biotech stocks rebounded in 2025. Wedbush’s Laura Chico explains why rare disease catalysts and upcoming data could shape the ...
Study for a foot of the Libyan Sibyl/Michelangelo (1475-1564) ...
Alström syndrome affects roughly one in 500,000 people. In May, Fort Worth will host a symposium of researchers looking into treatments.
Children in South Carolina are developing rare brain swelling complications after measles outbreak - The majority of the ...